Insmed Inc (INSM)
| Sector: | HEALTH CARE |
| Industry: | PHARMACEUTICALS |
| SIC: | PHARMACEUTICAL PREPARATIONS |
| CEO: | William H. Lewis |
| Employees: | 740 |
| Web site: | insmed.com |
| 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807 908-977-9900 | |
| Date | Ratio |
|---|---|
| 2011-03-03 | 1:10 |
| All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
|---|
Insmed Incorporated develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1.
Please log in first to see chart